Skip to main content

The Next Big Thing In Biotech: Decision Week

Ziopharm, AP Pharma and Biogen Idec will headline a very big week of approval decisions, Adam Feuerstein, Sr. Columnist at TheStreet, tells Gregg Greenberg.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.